Christine Loh - Publications

Affiliations: 
Pfizer, Inc., San Diego, CA, United States 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ciccone D, Lazari V, Linney I, Briggs M, Carreiro S, McElwee J, Waddell I, Hill C, Loh C, Tummino P, Collis A, Kaila N. 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model Journal For Immunotherapy of Cancer. 8: A724-A724. DOI: 10.1136/jitc-2020-sitc2020.0685  0.402
2020 Ciccone D, Lazari V, Linney I, Briggs M, Carreiro S, Waddell I, Hill C, Loh C, Tummino P, Collis A, Kaila N. A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model European Journal of Cancer. 138: S20. DOI: 10.1016/s0959-8049(20)31118-7  0.305
2019 Csibi F, Ji N, Yang B, Yuan K, Mayo M, Rong H, Rusin S, Sharma K, Loh C, Li H, Townson S, Chen J, Kamadurai H, Walker D, Gollob J, et al. Small Molecule-Induced, Selective STAT3 Degradation Leads to Anti-Tumor Activity in STAT3-Dependent Heme Malignancies Blood. 134: 3803-3803. DOI: 10.1182/Blood-2019-128981  0.313
2019 Kelleher JF, Campbell V, Chen J, Gollob J, Ji N, Kamadurai H, Klaus C, Li H, Loh C, McDonald A, Rong H, Rusin S, Sharma K, Vigil D, Walker D, et al. Abstract LB-272: KYM-001, a first-in-class oral IRAK4 protein degrader, induces tumor regression in xenograft models of MYD88-mutant ABC DLBCL alone and in combination with BTK inhibition Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-272  0.383
2019 Csibi F, Ji N, Yang B, Yuan K, Mayo M, Rong H, Rusin S, Sharma K, Loh C, Li H, Townson S, Kamadurai H, Chen J, Walker D, Gollob J, et al. Abstract C054: Discovery of KYM-003, a potent and selective STAT3 degrader with antitumor activity in heme malignancies Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C054  0.319
2018 Henry KL, Kellner D, Bajrami B, Anderson JE, Beyna M, Bhisetti G, Cameron T, Capacci AG, Bertolotti-Ciarlet A, Feng J, Gao B, Hopkins B, Jenkins T, Li K, May-Dracka T, ... ... Loh C, et al. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling. Science Signaling. 11. PMID 30065029 DOI: 10.1126/Scisignal.Aam8216  0.404
2012 Yang H, Zhang W, Pan H, Feldser HG, Lainez E, Miller C, Leung S, Zhong Z, Zhao H, Sweitzer S, Considine T, Riera T, Suri V, White B, Ellis JL, ... ... Loh C, et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. Plos One. 7: e46364. PMID 23029496 DOI: 10.1371/Journal.Pone.0046364  0.399
2012 Pau E, Cheung YH, Loh C, Lajoie G, Wither JE. TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice. Plos One. 7: e36761. PMID 22574220 DOI: 10.1371/Journal.Pone.0036761  0.314
2010 NIWAYAMA S, LOH C, TURK BE, LIU JO, MIYACHI H, HASHIMOTO Y. ChemInform Abstract: Enhanced Potency of Perfluorinated Thalidomide Derivatives for Inhibition of LPS-Induced Tumor Necrosis Factor-α Production is Associated with a Change of Mechanism of Action. Cheminform. 29: no-no. DOI: 10.1002/CHIN.199836166  0.601
1998 Niwayama S, Loh C, Turk BE, Liu JO, Miyachi H, Hashimoto Y. Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-α production is associated with a change of mechanism of action Bioorganic and Medicinal Chemistry Letters. 8: 1071-1076. PMID 9871710 DOI: 10.1016/S0960-894X(98)00171-1  0.588
1998 Sun L, Youn HD, Loh C, Stolow M, He W, Liu JO. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes Immunity. 8: 703-711. PMID 9655484 DOI: 10.1016/S1074-7613(00)80575-0  0.47
1996 Loh C, Carew JA, Kim J, Hogan PG, Rao A. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Molecular and Cellular Biology. 16: 3945-54. PMID 8668212 DOI: 10.1128/MCB.16.7.3945  0.319
1996 Loh C, Shaw KTY, Carew J, Viola JPB, Luo C, Perrino BA, Rao A. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity Journal of Biological Chemistry. 271: 10884-10891. PMID 8631904 DOI: 10.1074/Jbc.271.18.10884  0.316
Show low-probability matches.